Share of the population living with HIV receiving antiretroviral therapy in Australia

Australia: Share of the population living with HIV receiving antiretroviral therapy was 87.9% in 2023. ◆ Volatile

Latest (2023)
87.9%
Change on year
up 2.8%
World rank
27th
of 149 countries
All-time high
87.9%
in 2023
All-time low
0.0%
in 1990
Years of data
34
1990–2023

Share of the population living with HIV receiving antiretroviral therapy in Australia, 1990–2023

0204060801990200620231990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 13.3 %1997: 25.5 %1998: 36.3 %1999: 45.7 %2000: 52.6 %2001: 54 %2002: 51.2 %2003: 50.8 %2004: 50.8 %2005: 53.4 %2006: 56.5 %2007: 56.5 %2008: 55.4 %2009: 56.7 %2010: 61.8 %2011: 64.7 %2012: 67.9 %2013: 72.7 %2014: 76.2 %2015: 79.9 %2016: 81.1 %2017: 82.7 %2018: 82.5 %2019: 83.9 %2020: 84.7 %2021: 84.7 %2022: 85.6 %2023: 87.9 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

The most recent figure for share of the population living with hiv receiving antiretroviral therapy in Australia is 87.9%, measured in 2023. That is the highest value across all 34 years on record.

Compared with earlier readings it is up 2.8% on the previous year and up 20.9% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Australia peaked at 87.9% in 2023 and was at its lowest, 0.0%, in 1990.

That places Australia 27th out of 149 countries with data for 2023, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Australia, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Australia, 1990 to 2023.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 13.3% —
1997 25.5% +91.4%
1998 36.3% +42.2%
1999 45.7% +25.9%
2000 52.6% +15.1%
2001 54.0% +2.7%
2002 51.2% -5.2%
2003 50.8% -0.9%
2004 50.8% +0.1%
2005 53.4% +5.2%
2006 56.5% +5.7%
2007 56.5% +0.0%
2008 55.4% -2.0%
2009 56.7% +2.3%
2010 61.8% +9.0%
2011 64.7% +4.7%
2012 67.9% +4.8%
2013 72.7% +7.1%
2014 76.2% +4.9%
2015 79.9% +4.8%
2016 81.1% +1.5%
2017 82.7% +2.0%
2018 82.5% -0.1%
2019 83.9% +1.7%
2020 84.7% +0.9%
2021 84.7% +0.1%
2022 85.6% +1.0%
2023 87.9% +2.8%

Australia compared with similar countries

  • Australia's 87.9% is above the median for high income countries, which is 79.3%, 1.1× the median. (42 countries reporting)
  • Australia's 87.9% is above the median for East Asia & Pacific, which is 64.2%, 1.4× the median. (15 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Australia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
1997 +91.4% 13.3% 25.5%
1998 +42.2% 25.5% 36.3%

Averages by decade

DecadeAverage LowestHighest Years
1990s 12.1% 0.0% 45.7% 10
2000s 53.8% 50.8% 56.7% 10
2010s 75.3% 61.8% 83.9% 10
2020s 85.7% 84.7% 87.9% 4

Countries ranked near Australia

  1. 24 Iceland 88.2% compare
  2. 25 Belgium 88.1% compare
  3. 26 Cameroon 88.1% compare
  4. 28 Thailand 87.7% compare
  5. 29 Benin 87.5% compare
  6. 30 Kenya 87.1% compare

See the full ranking of 149 places →

More reference data data for Australia

All data for Australia →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Australia?
Share of the population living with hiv receiving antiretroviral therapy in Australia was 87.9% in 2023, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Australia?
The highest recorded value was 87.9% in 2023.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Australia?
The lowest recorded value was 0.0% in 1990.
How does Australia rank for share of the population living with hiv receiving antiretroviral therapy?
Australia ranks 27th out of 149 countries with data for 2023.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Australia?
Over the last ten years it is up 20.9%. The long-run trend across the full record is volatile.
Where does this Australia data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 34 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Australia. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/australia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/australia/">Share of the population living with HIV receiving antiretroviral therapy in Australia</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.